H. Thomas Temple, M.D., a sarcoma surgeon who treats cancers of the bone and soft tissue, has returned to Sylvester as the co-leader of the Sarcoma Site Disease Group and a mentor and educator who leads by example within the Department of Orthopaedics. He previously spent 17 years at the Miller School as an orthopaedic surgeon, clinician, and researcher.

“Dr. Tom Temple is a renowned sarcoma surgeon and researcher who will contribute greatly to our mission of building one of the strongest sarcoma programs in the world,” said Stephen D. Nimer, M.D., Sylvester director and the Oscar de la Renta Endowed Chair in Cancer Research.

Dr. Temple has studied the use of stem cells and other materials in regenerative medicine for more than two decades. He holds approximately 20 patents related to therapeutic strategies, such as combining stem cells with bone and cartilage allografts taken from cell and tissue donors. His research focus includes stem cell applications in regenerative medicine, tissue banking and developing targeted natural killer cell therapies for sarcomas.